COMP <GO>
XYL vs GGG // EV/EBITDA & P/E VALUATION
Xylem Inc. (NYSE) VS. Graco Inc. (NYSE) • 15-METRIC TALLY: XYL 4
— GGG 9
▲ EV/EBITDA & P/E VALUATION LEADER: XYL
LAST: $90.76 (+2.87%) • MKT CAP: $20.81B
valuation
13.2x
LAST: $68.75 (+2.37%) • MKT CAP: $11.03B
valuation
15.7x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (XYL VS. GGG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | XYL | GGG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 38.50% | 52.50% | -14.00 | GGG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.50% | 24.30% | -15.80 | GGG | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 13.2x | 15.7x | -2.50 | XYL | /valuation <GO> |
| Free Cash Flow Yield | 4.01% | 5.79% | -1.78 | GGG | /fcf-yield <GO> |
| Operating Margin | 13.50% | 27.90% | -14.40 | GGG | /operating-margins <GO> |
| Net Profit Margin | 10.60% | 23.30% | -12.70 | GGG | /net-margins <GO> |
| Revenue Growth (YoY) | 5.50% | 5.80% | -0.30 | GGG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.88% | 1.66% | +0.22 | XYL | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.28 | 6.51 | -3.23 | GGG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 31.6 | 35.4 | -3.80 | GGG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.91 | 0.89 | +0.02 | XYL | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.2x | 19.6x | +0.60 | GGG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $20.81B | $11.03B | $9.79B | XYL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | XYL REV | GGG REV | XYL GROSS % | GGG GROSS % | XYL FCF | GGG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $9.04B | $2.24B | 38.5% | 52.5% | $834.4M | $637.9M |
| FY 2024 | $8.56B | $2.11B | 37.5% | 53.1% | $877.7M | $515.0M |
| FY 2023 | $7.36B | $2.20B | — | — | $505.6M | $552.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
XYL // BETA 0.91
GGG // BETA 0.89